These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8958959)

  • 21. Antitumor treatment using interleukin- 12-secreting marrow stromal cells in an invasive glioma model.
    Hong X; Miller C; Savant-Bhonsale S; Kalkanis SN
    Neurosurgery; 2009 Jun; 64(6):1139-46; discussion 1146-7. PubMed ID: 19487894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative analysis of the sensitivity to natural killers and macrophages of 3-methylcholanthrene-induced tumors in mice].
    Viksler VKh; Iaroslavtseva OA; Lavroskiĭ VA
    Eksp Onkol; 1986; 8(6):36-40. PubMed ID: 3803287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Memory type 2 helper T cells induce long-lasting antitumor immunity by activating natural killer cells.
    Kitajima M; Ito T; Tumes DJ; Endo Y; Onodera A; Hashimoto K; Motohashi S; Yamashita M; Nishimura T; Ziegler SF; Nakayama T
    Cancer Res; 2011 Jul; 71(14):4790-8. PubMed ID: 21646476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunomodulatory gene therapy with interleukin 12 and 4-1BB ligand: long- term remission of liver metastases in a mouse model.
    Martinet O; Ermekova V; Qiao JQ; Sauter B; Mandeli J; Chen L; Chen SH
    J Natl Cancer Inst; 2000 Jun; 92(11):931-6. PubMed ID: 10841829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Murine models of cancer cytokine gene therapy using interleukin-12.
    Tahara H; Zitvogel L; Storkus WJ; Robbins PD; Lotze MT
    Ann N Y Acad Sci; 1996 Oct; 795():275-83. PubMed ID: 8958939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In situ tumor vaccination with interleukin-12-encapsulated biodegradable microspheres: induction of tumor regression and potent antitumor immunity.
    Egilmez NK; Jong YS; Sabel MS; Jacob JS; Mathiowitz E; Bankert RB
    Cancer Res; 2000 Jul; 60(14):3832-7. PubMed ID: 10919657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antitumour activities of cytokine-induced killer cells and dendritic cells in vitro and in vivo.
    Zhang S; Jiang SJ; Zhang CQ; Wang HM; Bai CX
    Chin Med J (Engl); 2005 Aug; 118(15):1308-12. PubMed ID: 16117888
    [No Abstract]   [Full Text] [Related]  

  • 29. Chemoimmunotherapy in mice carrying HPV16-associated, MHC class I+ and class I- tumours: Effects of CBM-4A potentiated with IL-2, IL-12, GM-CSF and genetically modified tumour vaccines.
    Indrová M; Bubeník J; Mikysková R; Mendoza L; Símová J; Bieblová J; Jandlová T; Jinoch P; Smahel M; Vonka V; Pajtasz-Piasecka E
    Int J Oncol; 2003 Mar; 22(3):691-5. PubMed ID: 12579325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bortezomib and IL-12 produce synergetic anti-multiple myeloma effects with reduced toxicity to natural killer cells.
    Wang X; Feng X; Wang J; Shao N; Ji C; Ma D; Henter JI; Fadeel B; Zheng C
    Anticancer Drugs; 2014 Mar; 25(3):282-8. PubMed ID: 24300915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adoptive immunotherapy in tumor-bearing mice with OK-432-induced killer cells.
    Ujiie T
    Jpn J Exp Med; 1988 Apr; 58(2):109-14. PubMed ID: 3261814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined delivery of a TGF-β inhibitor and an adenoviral vector expressing interleukin-12 potentiates cancer immunotherapy.
    Jiang J; Zhang Y; Peng K; Wang Q; Hong X; Li H; Fan G; Zhang Z; Gong T; Sun X
    Acta Biomater; 2017 Oct; 61():114-123. PubMed ID: 28483693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The potential of interleukin-12 for use in cancer therapy].
    Gately MK; Brunda MJ
    Gan To Kagaku Ryoho; 1996 Jul; 23(8):961-71. PubMed ID: 8687231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination treatment of murine tumors by adenovirus-mediated local B7/IL12 immunotherapy and radiotherapy.
    Lohr F; Hu K; Haroon Z; Samulski TV; Huang Q; Beaty J; Dewhirst MW; Li CY
    Mol Ther; 2000 Sep; 2(3):195-203. PubMed ID: 10985949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of early tumor growth requires J alpha 18-positive (natural killer T) cells.
    Stewart TJ; Smyth MJ; Fernando GJ; Frazer IH; Leggatt GR
    Cancer Res; 2003 Jun; 63(12):3058-60. PubMed ID: 12810627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant human prolactin improves antitumor effects of murine natural killer cells in vitro and in vivo.
    Sun R; Wei H; Zhang J; Li A; Zhang W; Tian Z
    Neuroimmunomodulation; 2002-2003; 10(3):169-76. PubMed ID: 12481157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo antitumor activity of NKT cells activated by the combination of IL-12 and IL-18.
    Baxevanis CN; Gritzapis AD; Papamichail M
    J Immunol; 2003 Sep; 171(6):2953-9. PubMed ID: 12960319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer.
    Smyth MJ; Swann J; Kelly JM; Cretney E; Yokoyama WM; Diefenbach A; Sayers TJ; Hayakawa Y
    J Exp Med; 2004 Nov; 200(10):1325-35. PubMed ID: 15545356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The immunomodulator thymalin in the experimental chemotherapy of tumors].
    Amosova EN; Iaremenko KV; Cherdyntseva NV; Nikolin VP; Ogreba VI
    Vopr Onkol; 1987; 33(10):68-72. PubMed ID: 3686911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic in vivo antitumor activity of interleukin-12 against both transplantable and primary tumor.
    Nishimura T; Watanabe K; Lee U; Yahata T; Ando K; Kimura M; Hiroyama Y; Kobayashi M; Herrmann SH; Habu S
    Immunol Lett; 1995 Dec; 48(2):149-52. PubMed ID: 8719115
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.